Cytiva News

  1. Cytiva Opens Cell Culture Center Of Excellence In Massachusetts 11/9/2022

    Global life sciences leader Cytiva opened a new Cell Culture Center of Excellence at its Marlborough, Massachusetts location.

  2. Cytiva Strengthens Cell Line Development With CEVEC Acquisition 10/6/2022

    Global life sciences leader Cytiva has acquired CEVEC Pharmaceuticals, a leading German provider of high-performance cell line development and viral vector manufacturing technologies. CEVEC will further strengthen Cytiva's leading position in biomanufacturing solutions.

  3. Cytiva Opens New Vancouver Manufacturing Site 7/27/2022

    Global life sciences leader Cytiva opened a new 126 200 ft2 (11 724 m2) site in the greater Vancouver area to expand manufacturing capacity of aseptic filling machines by over 200%.

  4. Cytiva Expanding US Operations 7/13/2022

    The new chromatography resins manufacturing site is part of Cytiva and Pall Corporation’s 1.5 billion USD capacity expansion investment.

  5. Cytiva Attains Business Continuity Management System ISO Certification 1/11/2022

    The new ISO 22301:2019 certification covers methods and procedures for maintaining emergency response, crisis management, and business continuity capabilities, including communication, implementation, and continual improvement.

  6. Cytiva Acquires GoSilico To Strengthen Digital Capabilities In Bioprocessing 6/2/2021

    Global life sciences leader Cytiva has acquired the German scientific software maker GoSilico, in a move that will differentiate Cytiva as a premier partner in bioprocessing.

  7. Cytiva Delivers KUBio To Lonza 1/14/2021

    Cytiva, a global life sciences leader, has successfully completed another KUBio installation, this time to global healthcare solutions provider Lonza, in Guangzhou Biopark, China.

  8. Cytiva's Fibro PrismA Technology Accelerates mAb Purification In LifeArc's Covid-19 Research 10/8/2020

    Cytiva, a global life sciences leader, made Fibro PrismA, the first product based on its new protein A fiber chromatography technology, available commercially earlier this year. The new technology is already accelerating research for customers and collaborators, such as LifeArc.

  9. New KUBio Box For Viral Vectors Boosts Gene Therapy Manufacturing 10/28/2019

    GE Healthcare Life Sciences is launching KUBio™ box, a fully-integrated, flexible, and adaptable biomanufacturing environment to accelerate the production of viral vector-based gene therapies. The latest addition to the KUBio modular bioprocessing portfolio, KUBio box is expected to speed gene therapies to market and contribute to increased capacity in the viral vector area.

  10. Lonza To Establish Strategic Biomanufacturing Base In China Using GE Healthcare Solution 12/10/2018

    Lonza recently announced an agreement with GE Healthcare under which GE Healthcare will deliver a biologics facility to Lonza in Guangzhou (CN).